Tumor induction of VEGF promoter activity in stromal cells

被引:809
作者
Fukumura, D
Xavier, R
Sugiura, T
Chen, Y
Park, EC
Lu, NF
Selig, M
Nielsen, G
Taksir, T
Jain, RK [1 ]
Seed, B
机构
[1] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Melvin B & Barbara K Nessel Gene Therapy Ctr, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA
关键词
D O I
10.1016/S0092-8674(00)81731-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have established a line of transgenic mice expressing the A. victoria green fluorescent protein (GFP) under the control of the promoter for vascular endothelial growth factor (VEGF). Mice bearing the transgene show green cellular fluorescence around the healing margins and throughout the granulation tissue of superficial ulcerative wounds. Implantation of solid tumors in the transgenic mice leads to an accumulation of green fluorescence resulting from tumor induction of host VEGF promoter activity. With time, the fluorescent cells invade the tumor and can be seen throughout the tumor mass. Spontaneous mammary tumors induced by oncogene expression in the VEGF-GFP mouse show strong stromal, but not tumor, expression of GFP. In both wound and tumor models the predominant GFP-positive cells are fibroblasts. The finding that the VEGF promoter of nontransformed cells is strongly activated by the tumor microenvironment points to a need to analyze and understand stromal cell collaboration in tumor angiogenesis.
引用
收藏
页码:715 / 725
页数:11
相关论文
共 38 条
  • [1] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS
    BERSE, B
    BROWN, LF
    VANDEWATER, L
    DVORAK, HF
    SENGER, DR
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) : 211 - 220
  • [2] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
    Boehm, T
    Folkman, J
    Browder, T
    OReilly, MS
    [J]. NATURE, 1997, 390 (6658) : 404 - 407
  • [3] A NEW MODEL FOR STUDYING MICROCIRCULATORY CHANGES DURING DERMAL WOUND-HEALING
    BONDAR, I
    UHL, E
    BARKER, JH
    GALLA, TJ
    HAMMERSEN, F
    MESSMER, K
    [J]. RESEARCH IN EXPERIMENTAL MEDICINE, 1991, 191 (06) : 379 - 388
  • [4] EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING
    BROWN, LF
    YEO, KT
    BERSE, B
    YEO, TK
    SENGER, DR
    DVORAK, HF
    VANDEWATER, L
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) : 1375 - 1379
  • [5] CERFBENSUSSAN N, 1983, J IMMUNOL, V130, P2615
  • [6] FACS-optimized mutants of the green fluorescent protein (GFP)
    Cormack, BP
    Valdivia, RH
    Falkow, S
    [J]. GENE, 1996, 173 (01) : 33 - 38
  • [7] Damert A, 1997, CANCER RES, V57, P3860
  • [8] DETMAR M, 1998, IN PRESS INVEST DERM
  • [9] DVORAK HF, 1995, AM J PATHOL, V146, P1029
  • [10] DVORAK HF, 1986, NEW ENGL J MED, V315, P1650